SRP
CLB icon

Saddle Road Partners’s Core Laboratories CLB Stock Holding History

Saddle Road Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-34,217
Closed -$3.85M – 123
2016
Q1 		$3.85M Buy
34,217
+3,426
+11% +$356K 2.44% 13
2015
Q4 		$3.35M Buy
+30,791
New +$3.52M 2.3% 13

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Saddle Road Partners's CLB Position: Q2 2016 in Review

Saddle Road Partners sold out of Core Laboratories (CLB) in Q2 2016, closing a stake of 34,217 shares — an estimated $3.85M sold.

Saddle Road Partners first reported a position in CLB in Q4 2015 and held it in 2 quarters. The position peaked at $3.85M in Q1 2016. 383 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

  • Saddle Road Partners reported no remaining Core Laboratories position as of Q2 2016 after selling out during the quarter.
  • Saddle Road Partners sold 34,217 Core Laboratories shares in Q2 2016, an estimated $3.85M.
  • Saddle Road Partners first reported a position in Core Laboratories in Q4 2015 and held it in 2 quarters.
  • Saddle Road Partners's Core Laboratories position peaked at $3.85M in Q1 2016.
  • 383 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on Saddle Road Partners's 13F filing for Q2 2016, filed 12 Jul 2016.